✦ LIBER ✦

Gonadal Failure with Cyclophosphamide Therapy for Lupus Nephritis: Advances in Fertility Preservation

✍ Scribed by Mersereau, Jennifer; Dooley, Mary Anne

Book ID: 120483898
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 99 KB
Volume: 36
Category: Article
ISSN: 0889-857X
DOI: 10.1016/j.rdc.2009.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gonadal Failure with Cyclophosphamide Th

Gonadal Failure with Cyclophosphamide Therapy for Lupus Nephritis: Advances in Fertility Preservation

✍ Mersereau, Jennifer; Dooley, Mary Anne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Prevention of gonadal toxicity and prese

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study

✍ Karin Manger; Ludwig Wildt; Joachim R. Kalden; Bernhard Manger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Induction therapy with low-dose intraven

Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children

✍ Shuichiro Fujinaga; Kazunari Kaneko; Yoshiyuki Ohtomo; Hitohiko Murakami; Masaru 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 322 KB

Risk factors for ovarian failure in pati

Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

✍ Chi Chiu Mok; Chak Sing Lau; Raymond Woon Sing Wong 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

## Objective: To determine the incidence of ovarian failure after cyclophosphamide (cyc) treatment for systemic lupus erythematosus (sle) and to identify the risk factors for this complication. ## Methods: The records of 70 premenopausal female sle patients treated with cyc were reviewed retrospe

Use of a gonadotropin-releasing hormone

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

✍ Emily C. Somers; Wendy Marder; Gregory M. Christman; Vladimir Ognenovski; W. Jos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study was performed to evaluate the effectiveness